Xilio Therapeutics, Inc.
Ticker: XLO
| Insider | Title |
|---|---|
| (imf) Gp Llp Sv7 | 10% or greater ownership |
| Aoife Brennan | Director |
| Capital Life Sciences Fund Ii, L.p. Bain | 10% or greater ownership |
| Capital Life Sciences Investors Ii, Llc Bain | 10% or greater ownership |
| Capital Life Sciences Investors, Llc Bain | 10% or greater ownership |
| Christina Rossi | Director |
| Christopher James Frankenfield | Chief Operating Officer |
| City Capital Llc Bay | 10% or greater ownership |
| Daniel J. Curran | Director |
| Daniel Lynch | Director |
| Edward C English | Principal Accounting Officer |
| Ii Investco, Lp Bcls | 10% or greater ownership |
| Ii Investo (gp), Llc Bcls | 10% or greater ownership |
| Impact Medicine Fund Lp Sv7 | 10% or greater ownership |
| James E Flynn | Possible Members of 10% Group, 10% or greater ownership |
| James Samuel Shannon | Director |
| John Charles Williams | 10% or greater ownership |
| Katarina Luptakova | CHIEF MEDICAL OFFICER |
| Kevin M. Brennan | SVP, FINANCE AND ACCOUNTING |
| Kgaa Merck | 10% or greater ownership |
| Life Sciences Associates, Lp Bcip | 10% or greater ownership |
| Llc Fmr | See Remark 1, 10% or greater ownership |
| Llc Gkcc, | 10% or greater ownership |
| Ltd Fil | See Remark 1 |
| Management Company, L.p. (series C) Deerfield | Possible Members of 10% Group, 10% or greater ownership |
| Martin H. Jr. Huber | PRESIDENT AND HEAD OF RD |
| Mgmt L.p. Deerfield | Possible Members of 10% Group, 10% or greater ownership |
| Mgmt V, L.p. Deerfield | Possible Member of 10% Group, 10% or greater ownership |
| Michael Jay Ross | Director |
| Of Ulrich Rodeck Estate | 10% or greater ownership |
| Partners, L.p. Deerfield | Possible Members of 10% Group, 10% or greater ownership |
| Paul J Clancy | Director |
| Pharmaceutical Co Ltd Takeda | 10% or greater ownership |
| Pines Master Fund Lp Four | 10% or greater ownership |
| Rachel Humphrey | Director |
| Rene Russo | PRESIDENT AND CEO, Director |
| Robert W. Ross | Director |
| Salvatore Giovine | CHIEF FINANCIAL OFFICER |
| Sara Bonstein | Director |
| Sciences, Inc. Gilead | 10% or greater ownership |
| Simon M Tomlinson | 10% or greater ownership |
| Springs Capital Llc Rock | 10% or greater ownership |
| Springs Capital Management Lp Rock | 10% or greater ownership |
| Springs Capital Master Fund Lp Rock | 10% or greater ownership |
| Timothy P Clackson | President and CEO, Director |
| Tomas J. Heyman | Director |
| Venture Associates Opportunity I, L.p. Atlas | 10% or greater ownership |
| Venture Associates Opportunity I, Llc Atlas | 10% or greater ownership |
| Venture Associates Xi, L.p. Atlas | 10% or greater ownership |
| Venture Associates Xi, Llc Atlas | 10% or greater ownership |
| Venture Fund Iv, L.p. Rivervest | 10% or greater ownership |
| Venture Fund Xi, L.p. Atlas | 10% or greater ownership |
| Venture Investments, Llc Alexandria | 10% or greater ownership |
| Venture Opportunity Fund I, L.p. Atlas | 10% or greater ownership |
| Ventures, Inc. Takeda | 10% or greater ownership |
| Yekaterina Chudnovsky | 10% or greater ownership |
| Yuan Xu | Director |